Associated Papers
Germline Mutations in Patients With Early-Onset Prostate Cancer.
Tang T et al.
Frontiers in Oncology, 2022
Hereditary variants of unknown significance in African American women with breast cancer.
McDonald JT et al.
Plos One, 2022
36315513 (PubMed )
Supplement: pone.0273835.s001.xlsx › ConsensusScores
Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer.
Sipeky C et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2018
Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.
Tan SH et al.
International Journal of Molecular Sciences, 2018
HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions.
Brechka H et al.
Genes & Diseases, 2017
Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients.
Maia S et al.
Plos One, 2015
A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
Karlsson R et al.
European Urology, 2014
Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer.
Decker B et al.
Pharmacogenomics and Personalized Medicine, 2014
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
Xu J et al.
Human Genetics, 2013
Germline mutations in HOXB13 and prostate-cancer risk.
Ewing CM et al.
The New England Journal of Medicine, 2012
Select a paper to view details